O

OMass Therapeutics

59 employees

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical
Life Science

Date founded

2016

Funding rounds raised

Total raised

$95M

from 12 investors over 12 rounds

O

OMass Therapeutics raised $13M on May 15, 2023

Investors: British Patient Capital

O

OMass Therapeutics raised $95M on April 27, 2022

Investors: Sanofi Ventures, Oxford Sciences Innovation, Northpond Ventures, Syncona Limited, University of Oxford and GV

O

OMass Therapeutics raised $36M on February 17, 2020

Investors: Oxford Sciences Innovation and Syncona Limited

O

OMass Therapeutics raised $18M on November 21, 2018

Investors: Oxford Sciences Innovation and Syncona Limited

O

OMass Therapeutics raised $1.4M on June 14, 2016

Investors: Oxford Sciences Innovation

FAQ